All News

Could This Lipoma Be Another Cancer?

April 7th 2022

I have a lipoma on my back, and since I’m worried about both the aesthetics and potential malignancy of the fatty tumor, I’ve decided to have it removed.

First-in-Human Trial of an Investigational Cell Therapy for Advanced Gynecologic Cancers Treats First Patient

April 7th 2022

The first patient was dosed in an early-phase trial evaluating the investigational cell therapy DeTIL-0255 for the treatment of advanced ovarian, cervical and endometrial cancer.

Educated Patient® Multiple Myeloma Summit CAR/BiTE Presentation: March 12, 2022

April 7th 2022

Watch Dr. Sham Mailankody, from Memorial Sloan Kettering Cancer Center, discuss CAR and BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

Novel Treatment Given to First Patient in Trial Assessing the Drug’s Safety and Efficacy in Solid Tumors With Certain Genetic Alterations

April 6th 2022

Researchers have treated the first patient in the PRECISION 1 trial with Fyarro to assess the drug’s efficacy across several endpoints including survival among more than 100 patients with solid tumors that exhibit certain genetic alterations.

Now That Telemedicine is a Mainstay in Cancer Care, One Expert Notes When Patients Should Opt for Virtual Appointments

April 6th 2022

The COVID-19 pandemic brought on a huge surge in the use of telemedicine for cancer care, but now as the pandemic is slowing down, an expert said that there are certain times when telemedicine will do, while other situations warrant an in-person visit with the doctor.

I Can't Stop Mourning the Way Life Used to Be Before COVID-19

April 6th 2022

Going through the COVID-19 pandemic with a cancer diagnosis made me feel jittery, and I know that many others felt the same way, too.

Can a Skin Patch Effectively Control Chemotherapy-Induced Nausea, Vomiting?

April 6th 2022

An upcoming phase 2 study will explore if the transdermal (through the skin) delivery of a drug commonly used to treat nausea and vomiting will result in no nausea, no vomiting and no use of rescue medicines in patients with cancer receiving chemotherapy.

Educated Patient® Multiple Myeloma Summit MM4MM Keynote Lecture: March 12, 2022

April 6th 2022

Watch Dr. Saad Z. Usmani, Dr. Ben Marcus and Stan Wagner discuss their participation in the Moving Mountains for Multiple Myeloma program, during the CURE Educated Patient Multiple Myeloma Summit.

First Patient With Lymphoma Receives Novel Cell Therapy in Large-Scale Trial

April 5th 2022

The plan is to assess the safety and efficacy of the genetically engineered cell therapy alongside high-dose chemotherapy and blood stem cell transplantation in approximately 150 patients with lymphoma.

‘Monumental’ Treatment Advancements Have Been ‘Life-Changing’ For Many Patients With Thyroid Cancer

April 5th 2022

Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.

Crazy Cancer Cures: Google is Not Your Friend

April 5th 2022

After being diagnosed with cancer, I scoured the internet for ways to live as long as possible and found some helpful tips and not-so-helpful “cures.”

Opdivo-Yervoy Combo Treatment May Prolong Survival Without Disease Progression in Subgroup of Patients With Resectable Liver Cancer

April 5th 2022

“Combination therapy with (Opdivo) plus (Yervoy) warrants further studies in the preoperative setting for patients with resectable hepatocellular carcinoma, which could transform the role of immunotherapy from palliative treatment in the metastatic setting to curative treatment in localized disease,” the study authors wrote.

Educated Patient® Multiple Myeloma Summit Myeloma Treating Myeloma Long-Term Panel: March 12, 2022

April 5th 2022

Watch Kristie L. Kahl, Donna and Jack McNutt, Dr. Noopur Raje, and Grace Allison, discuss treating myeloma long term, during the CURE Educated Patient Multiple Myeloma Summit.

First Patient Receives Novel Antibody in Early-Phase Trial Assessing Safety, Efficacy of the Drug in Several Solid Tumor Types

April 4th 2022

A patient with an advanced solid tumor was given their first dose of a novel antibody, kicking off a phase 1/1b study comparing this drug with or without Keytruda in patients with several types of solid tumors.

Enhertu Bests Standard of Care in Potentially Preventing Disease Progression, Death in Previously Treated HER2-Positive Metastatic Breast Cancer

April 4th 2022

Certain patients with metastatic breast cancer may benefit from Enhertu compared with standard of care with Kadcyla despite higher rates of side effects including lung inflammation and interstitial lung disease.

Rude Front-Desk Workers Can Set a Bad Tone for an Oncology Visit

April 4th 2022

When visiting the cancer center (or any other health care center), the people who greet me at the front desk can have a major impact on the whole experience.

FDA Approves Yescarta, First CAR-T Cell Therapy, for Patients With Large B-Cell Lymphoma That Has Failed Initial Treatment

April 4th 2022

The FDA’s decision to approve Yescarta in patients with large B-cell lymphoma that has failed to respond to first-line treatment is based on data that showed that the use of the CAR-T cell therapy resulted in a significant increase in patients who were alive at two years compared with the standard-of-care second-line treatment.

Educated Patient® Multiple Myeloma Summit Myeloma Treatment Panel: March 12, 2022

April 4th 2022

Watch Dr. Saad Z. Usmani, Dr. Krina K. Patel, Dr. Noa Biran, and Jenny Ahlstrom, answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Relapsed/Refractory Myeloma Presentation: March 12, 2022

April 3rd 2022

Watch Dr. Noa Biran, an associate professor of medicine in the division of multiple myeloma at The John Theurer Cancer Center at Hackensack University Medical Center, discuss treatment for relapsed/refractory myeloma.

Here We Go Again: After Already Overcoming Multiple Obstacles This Year, Another Cancer Treatment Regimen is on My Horizon

April 2nd 2022

The year 2022 has already been filled with obstacles and heartache — as well plans for a new cancer treatment — but I’m putting away the bad thoughts to get ready for the fight ahead of me.

Educated Patient® Multiple Myeloma Summit Newly Diagnosed Myeloma Presentation: March 12, 2022

April 2nd 2022

Watch Dr. Krina K. Patel, an associate professor and center medical director for the Department of Lymphoma-Myeloma at The University of Texas MD Anderson Cancer Center discuss treatment for newly diagnosed myeloma.

Utilizing Integrative Care in Metastatic Breast Cancer

April 1st 2022

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Andrea Kassem discusses integrative care in metastatic breast cancer.

‘Driving Your Care’: Planning Treatment of Breast Cancer-Related Brain Metastases

April 1st 2022

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for patients with breast cancer that has metastasized to the brain.

Patient Offers Advice on Advocating for Quality of Life, Second Opinions in Metastatic Breast Cancer

April 1st 2022

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Myra Camino discusses her experience as a patient advocating for herself after her stage 4 metastatic breast cancer diagnosis.

Being Involved in Decision-Making Through the Multidisciplinary Approach to Metastatic Breast Cancer Care

April 1st 2022

In CURE’s Speaking Out video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses the multidisciplinary approach to metastatic breast cancer care.

Patient With Leukemia Subtype Undergoes Stem Cell Transplant After Receiving Novel Monotherapy in Early-Phase Trial

April 1st 2022

Treatment with a novel monotherapy in a patient with relapsed/refractory acute myeloid leukemia was effective enough that a successful, as indicated by a significant reduction in bone marrow blasts, stem cell transplant was performed.

Why I'm Sensitive About Labels Like ‘Survivor’ and ‘Cancer-Free’

April 1st 2022

Motivating affirmations are one thing, but to me, labels like “survivor” and “cancer-free” are a touchy subject.

New York Yankees Player Gifts Custom Baseball Cards to Cancer Survivor, 'Good Morning America' Host Robin Roberts Discusses Hair Loss During Cancer Treatment and More

April 1st 2022

From New York Yankees outfielder Aaron Judge giving a brain cancer survivor custom baseball cards to Tom Parker’s brain cancer death and Good Morning America’s Robin Roberts opening up about her cancer experience, here’s what is happening in the cancer space this week.

Educated Patient® Multiple Myeloma Summit Basics of Myeloma Panel: March 12, 2022

April 1st 2022

Watch Saad Z. Usmani, MD, MBA, with Carlyn Rose Tan, MD; Neha S. Korde, MD; and Kenny Capps answer audience Q&A during the CURE Educated Patient Multiple Myeloma Summit.

FDA to Speed Up Review of Futibatinib to Treat Certain Patients With Cholangiocarcinoma

March 31st 2022

The FDA plans to decide on whether to approve futibatinib for the treatment of patients with previously treated, locally advanced or metastatic cholangiocarcinoma that harbors a certain genetic mutation by September.